Tandem Diabetes Care (TNDM) Competitors $15.40 -0.18 (-1.16%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$15.69 +0.29 (+1.88%) As of 08/1/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TNDM vs. IRTC, SLNO, INSP, TMDX, NVST, PRCT, WRBY, LIVN, EYE, and LMATShould you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Tandem Diabetes Care vs. Its Competitors iRhythm Technologies Soleno Therapeutics Inspire Medical Systems TransMedics Group Envista PROCEPT BioRobotics Warby Parker LivaNova National Vision LeMaitre Vascular Tandem Diabetes Care (NASDAQ:TNDM) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability. Is TNDM or IRTC more profitable? iRhythm Technologies has a net margin of -14.06% compared to Tandem Diabetes Care's net margin of -18.71%. Tandem Diabetes Care's return on equity of -57.33% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-18.71% -57.33% -13.48% iRhythm Technologies -14.06%-95.60%-8.61% Do analysts rate TNDM or IRTC? Tandem Diabetes Care currently has a consensus target price of $32.71, suggesting a potential upside of 112.43%. iRhythm Technologies has a consensus target price of $157.30, suggesting a potential downside of 4.65%. Given Tandem Diabetes Care's higher possible upside, equities research analysts clearly believe Tandem Diabetes Care is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 1 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.36iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Which has stronger valuation & earnings, TNDM or IRTC? Tandem Diabetes Care has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$982.95M1.04-$96.03M-$2.78-5.54iRhythm Technologies$591.84M8.90-$113.29M-$3.14-52.54 Does the media favor TNDM or IRTC? In the previous week, iRhythm Technologies had 15 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 22 mentions for iRhythm Technologies and 7 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.02 beat iRhythm Technologies' score of 0.87 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 9 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, TNDM or IRTC? Tandem Diabetes Care has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. SummaryTandem Diabetes Care beats iRhythm Technologies on 8 of the 14 factors compared between the two stocks. Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNDM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNDM vs. The Competition Export to ExcelMetricTandem Diabetes CareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$6.77B$5.48B$9.51BDividend YieldN/A1.32%4.73%4.08%P/E Ratio-5.5420.9428.6723.80Price / Sales1.0454.14373.9066.65Price / CashN/A20.5035.4557.96Price / Book3.844.468.275.55Net Income-$96.03M$174.54M$3.24B$259.03M7 Day Performance-3.08%-5.27%-3.69%-4.59%1 Month Performance-9.84%-3.94%4.33%4.46%1 Year Performance-63.04%8.26%25.95%18.03% Tandem Diabetes Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNDMTandem Diabetes Care3.5007 of 5 stars$15.40-1.2%$32.71+112.4%-56.3%$1.04B$982.95M-5.542,650Positive NewsUpcoming EarningsIRTCiRhythm Technologies1.803 of 5 stars$137.11+2.2%$137.30+0.1%+95.9%$4.38B$618.59M-43.672,000Trending NewsEarnings ReportAnalyst ForecastGap UpSLNOSoleno Therapeutics4.2762 of 5 stars$85.25-1.4%$108.70+27.5%+74.8%$4.30BN/A-18.4530Positive NewsUpcoming EarningsINSPInspire Medical Systems4.7246 of 5 stars$130.72+1.4%$208.55+59.5%-13.1%$3.86B$840.11M60.241,246Positive NewsUpcoming EarningsTMDXTransMedics Group2.4919 of 5 stars$105.24-2.7%$129.88+23.4%-20.4%$3.56B$441.54M77.38210Trending NewsEarnings ReportAnalyst ForecastNVSTEnvista3.5854 of 5 stars$20.73-0.3%$20.23-2.4%+22.7%$3.51B$2.51B-3.1712,300Trending NewsEarnings ReportAnalyst ForecastPRCTPROCEPT BioRobotics2.5081 of 5 stars$54.08-2.9%$84.13+55.6%-19.4%$2.99B$224.50M-31.81430Upcoming EarningsWRBYWarby Parker2.1031 of 5 stars$24.10-1.2%$22.88-5.1%+48.9%$2.52B$771.32M-200.833,780News CoveragePositive NewsUpcoming EarningsAnalyst ForecastShort Interest ↑Gap DownLIVNLivaNova2.9483 of 5 stars$43.46-0.5%$59.29+36.4%-14.9%$2.37B$1.25B-10.632,900News CoverageUpcoming EarningsEYENational Vision2.8527 of 5 stars$24.48-2.2%$23.00-6.0%+78.3%$1.94B$1.85B-74.1813,411Positive NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionLMATLeMaitre Vascular2.9769 of 5 stars$82.47+0.0%$97.83+18.6%-6.0%$1.86B$219.86M41.65490Upcoming Earnings Related Companies and Tools Related Companies IRTC Alternatives SLNO Alternatives INSP Alternatives TMDX Alternatives NVST Alternatives PRCT Alternatives WRBY Alternatives LIVN Alternatives EYE Alternatives LMAT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNDM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNDM Stock Alerts